Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dorland Public Relations, historically known as Dorland Global Health Communications, was a leading independent healthcare communications agency that provided strategic public relations, advertising, and medical education services to the pharmaceutical and biotechnology industries. Headquartered in Philadelphia, the firm was recognized for its expertise in product launches and corporate reputation management for major life science companies. In 2004, the agency was acquired by the UK-based communications group Huntsworth for approximately $38 million, becoming a core part of their healthcare division. Following subsequent industry consolidations, including the merger of Huntsworth and Ashfield, the entity's operations have been integrated into the global healthcare services platform Inizio. The firm's legacy is rooted in its status as one of the oldest advertising names in the United States, dating back to 1883.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dorland Public Relations.